glp-1 and steroids Steroid hyperglycemia: Prevalence, early detection therapeutic recommendations: A narrative review GLP-1 Agonists in Transplant Patients:

Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia

Here's the current landscape: Brand Name Oral Semaglutide (Wegovy pill): Novo Nordisk announced a limited-time price of $149/month for the starting dose Higher doses (25mg) may cost more Launched in January 2026 Additional costs may apply such as labs, consultations, shipping and membership Brand Name Injectable GLP-1s: Wegovy: $1,000-1,500/month without insurance Ozempic: $900-1,000/month without insurance Mounjaro/Zepbound: $1,000-1,400/month without insurance Compounded Injectable GLP-1s: Affinity Whole Health: Starting at $299/month for compounded semaglutide Includes medications, supplies, shipping, and ongoing support Significant savings compared to brand names Compounded ODT Formulations: Prices vary widely, typically $299-449/month for compounded semaglutide or tirzepatide ODTs Generally more expensive than compounded injectables Available through compounding pharmacies Currently, compounded injectable medications from FDA-registered facilities remain the most cost-effective option for most patients seeking GLP-1 therapy

GLP-1 supplementation had healed the intestinal lesions (Figure 2A)

Tools: Use apps like Shotsy for medication tracking or smart scales for automated weight logging

In 2022, the FDA added both semaglutide and tirzepatide to its drug-shortage list

There are two approaches (and its possible to combine both): Stay at the Starter Dose